Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.05
-0.07 (-0.98%)
Nov 20, 2026, 4:00 PM EST - Market closed
Puma Biotechnology Employees
Puma Biotechnology had 179 employees as of December 31, 2025. The number of employees increased by 7 or 4.07% compared to the previous year. That makes Puma Biotechnology the 27,615th largest employer in the world and 3,471st in the United States.
Employees
179
Change (1Y)
7
Growth (1Y)
4.07%
Revenue / Employee
$1,295,112
Profits / Employee
$133,128
Market Cap
364.47M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 179 | 7 | 4.07% |
| Dec 31, 2024 | 172 | -13 | -7.03% |
| Dec 31, 2023 | 185 | -7 | -3.65% |
| Dec 31, 2022 | 192 | -4 | -2.04% |
| Dec 31, 2021 | 196 | -71 | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| ARS Pharmaceuticals | 206 |
| MapLight Therapeutics | 133 |
| Alector | 103 |
| Prelude Therapeutics | 79 |
| Larimar Therapeutics | 71 |
| Candel Therapeutics | 55 |
| Contineum Therapeutics | 51 |
PBYI News
- 16 days ago - Puma Biotechnology reports Q3 adjusted EPS 15c vs 21c last year - TheFly
- 16 days ago - Puma Biotechnology Earnings Call Transcript: Q3 2026 - Transcripts
- 16 days ago - Puma Biotechnology Earnings release: Q3 2026 - Filings
- 16 days ago - Puma Biotechnology Slides: Q3 2026 - Filings
- 16 days ago - Puma Biotechnology Quarterly report: Q3 2026 - Filings
- 16 days ago - Puma Biotechnology Reports Third Quarter 2026 Financial Results - Business Wire
- 17 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2026 Financial Results - Business Wire